Awa, Stewie B.

HRN: 20-92-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/18/2022
05/24/2022
IV
400mg
Q6h
PCAP C With HRAD
Waiting Final Action 
05/19/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
05/19/2022
05/25/2022
PO
2 Ml
OD
Interstitial Pnuemonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: